Search | Médecins Sans Frontières Access Campaign

21 results found

Image of bedaquiline, TB drug at the MSF project in Osh, Kyrgyzstan, 2017.

Press release |

23 October 2018

MSF warns high prices of tuberculosis drugs restrict people's access to best drug-resistant TB treatment

We call on US pharma corporation Johnson & Johnson to cut key TB drug price in half

Tags Tuberculosis drug-resistant TB bedaquilinedelamanid patent pool Union Conference on Lung HealthWorld Health OrganizationJohnson & Johnson DRTB Drugs Under the Microscope Netherlands

Statement |

26 October 2011

Statement by MSF in response to WIPO announcement of Re:Search, Consortium for Neglected Tropical Diseases, TB and Malaria

Tags Research and development malarianeglected diseasestuberculosis patent pool

Interview |

08 August 2011

Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries

Tags HIV/AIDSIntellectual property and trade HIV/AIDS raltegravirantiretroviral medicines compulsory licencepatent poolTRIPS Brazil

Catherine Atieno lives with her family in Kibera, a deprived area of the Kenyan capital, Nairobi. Catherine is HIV positive and is being treated at an MSF clinic in Kibera where she also works as a cleaner and a cook. Seven years ago, after she had started antiretroviral treatment, Catherine documented her life in pictures in a project called ÔMy Life with HIVÕ.

Press release |

12 July 2011

Gilead Licence Expands Access, But Several Countries Left Out

Tags HIV/AIDS HIV/AIDS compulsory licencepatent pool Gilead BrazilIndiaThailand

Press release |

25 April 2011

Johnson & Johnson Turns Its Back on AIDS Patients

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicinesdarunavirrilpivirine patent pool Johnson & Johnson

Research article |

27 March 2011

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

Tags HIV/AIDSIntellectual property and trade HIV/AIDS patent poolresearch and development (R&D)

Report |

10 March 2011

2011 Special 301 Review

Tags Intellectual property and trade Doha Declarationfree trade agreementpatent poolTRIPS

Press release |

28 January 2011

Johnson & Johnson/ Tibotec AIDS Drug Licenses Leave Out Too Many Patients

Tags HIV/AIDSIntellectual property and trade antiretroviral medicinesrilpivirine patent poolvoluntary licence Johnson & JohnsonTibotec South AfricaIndia

Report |

04 January 2011

10 Stories that Mattered to Access to Medicines in 2010

Tags Intellectual property and trade severe malariatuberculosismeaslesHIV/AIDS vaccines free trade agreementpatent pool

Press release |

30 September 2010

First patent goes into the Medicines Patent Pool - drug companies must now follow suit

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicinesdarunavir patent pool

Statement |

12 February 2010

Heat-stable ritonavir approved

Tags HIV/AIDSIntellectual property and trade lopinavir/ritonavir patent pool UNITAIDAbbott

Press release |

15 December 2009

UNITAID Patent Pool: Innovative Initiative Designed to Boost Access to Medicines is Adopted

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines patent pool UNITAID

Press release |

08 December 2009

UNITAID Patent Pool: Key Developing Countries at Risk of Being Excluded

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines patent pool UNITAID

Press release |

30 September 2009

MSF calls on drug companies to pool HIV patents

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicines patent pool

Events |

28 July 2009

Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing

Tags HIV/AIDS HIV/AIDS antiretroviral medicines patent pool UNITAID

Press release |

20 July 2009

Optimise now, or pay more later…Sub-optimal treatment threatens long-term survival of people living with HIV/AIDS

Tags HIV/AIDSIntellectual property and tradeResearch and development HIV/AIDS antiretroviral medicines patent pool International AIDS ConferenceUNITAID South Africa

Press release |

16 February 2009

MSF response to GSK patent pool proposal

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines patent pool UNITAIDGlaxoSmithKline

Opinion article |

02 February 2009

A patent pool for medicines

Tags Intellectual property and trade antiretroviral medicines patent pool

Report |

16 January 2009

The Global Politics of Pharmaceutical Monopoly Power

Tags Intellectual property and tradeResearch and development compulsory licenceDoha Declarationfree trade agreementpatent poolTRIPS South AfricaIndia

Events |

08 August 2008

Mexico IAS satellite: Taking the Plunge

Tags Intellectual property and trade antiretroviral medicines patent pool International AIDS ConferenceUNITAID

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF warns high prices of tuberculosis drugs restrict people's access to best drug-resistant TB treatment

Statement by MSF in response to WIPO announcement of Re:Search, Consortium for Neglected Tropical Diseases, TB and Malaria

Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries

Gilead Licence Expands Access, But Several Countries Left Out

Johnson & Johnson Turns Its Back on AIDS Patients

Driving a decade of change: HIV/AIDS, patents and access to medicines for all

2011 Special 301 Review

Johnson & Johnson/ Tibotec AIDS Drug Licenses Leave Out Too Many Patients

10 Stories that Mattered to Access to Medicines in 2010

First patent goes into the Medicines Patent Pool - drug companies must now follow suit

Heat-stable ritonavir approved

UNITAID Patent Pool: Innovative Initiative Designed to Boost Access to Medicines is Adopted

UNITAID Patent Pool: Key Developing Countries at Risk of Being Excluded

MSF calls on drug companies to pool HIV patents

Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing

Optimise now, or pay more later…Sub-optimal treatment threatens long-term survival of people living with HIV/AIDS

MSF response to GSK patent pool proposal

A patent pool for medicines

The Global Politics of Pharmaceutical Monopoly Power

Mexico IAS satellite: Taking the Plunge